New Germinator and AREV Nanotec Brands Agreement Aids Refugees

VANCOUVER, British Columbia — AREV Nanotec Brands, a publicly traded life science enterprise, and Germinator, a leading sanitizing and disinfecting company, have entered into an agreement that will aid refugees and internally displaced persons (IDPs) through Central and South America, Africa, eastern Europe and Asia.

The agreement provides the Genesis platform of hypochlorous acid (HOCl) surface disinfectants to global public health programs to aid refugees and IDPs.

Through the partnership, Germinator grants AREV exclusive rights to distribute Germinator products to any refugee camp, United Nations-run facility, UNICEF site or similar facility on a worldwide basis. In exchange, Germinator will receive AREV publicly traded shares equivalent to $50,000 USD at a price per share equal to $0.25 CAD, which amounts to 261,000 shares of AREV common stock traded on the Canadian Securities Exchange.

Refugee and IDP camps continue to experience a profound health crisis related to COVID-19 as well as drug-resistant variants of other infectious diseases, such as Extensively Drug-Resistant Tuberculosis. The distribution partnership will provide these populations with ongoing access to surface disinfectant treatments and air filtration systems to help curtail the transmission of contagious pathogens.

Programs subject to the agreement include the World Health Organization; the International Red Cross and Red Crescent Movement; Médecins Sans Frontières; Partners In Health; The U.S. President's Emergency Plan for AIDS Relief; Supply Chain Management System; John Snow Inc.; United Nations High Commissioner for Refugees; International Organization for Migration; World Food Programme; International Rescue Committee; Danish Refugee Council; Oxfam; Mercy Corps; Catholic Relief Services; and others.

“This collaboration between AREV and Germinator to expand the utility of the Genesis HOCl disinfection solution into the public health venues that are at greatest risk for highly contagious infectious disease will provide demonstratable solutions essential to vulnerable populations,” said Jeff Gill, Germinator founder and CEO. “There are over 70 million people subject to significant overcrowding in more than 100 IDP and refugee camps around the world. These camps are being administrated by an unprecedented number of organizations that have continued to express their deepening concerns regarding current overcapacities as it relates to remediating the potential for new epidemics emerging during the current public health crisis.”

Germinator’s platform of disinfecting products includes electrostatic sprayers and drone distribution that dispense Germinator’s disinfectant solution. Germinator’s HOCl disinfecting solution is on the EPA N List of products determined to meet the criteria for use against COVID-19 and other microbes.

The solution is a virucide against a wide range of bacteria, including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists germicidal spray standards for hospital-grade disinfection.

There is an immediate need for surface transmission remediation and improved sanitation in refugee and IDP populations as variants of infectious diseases continue to mutate.

“While global health leaders are working to address COVID-19 among key populations in resource-challenged nations, ongoing remediation of deadly pathogens other than COVID-19 is imperative for the prevention of future catastrophic pandemics, which often begin within vulnerable, transient populations,” said Chad S. Johnson, Esq., special counsel to AREV and strategic policy advisor to Germinator.  “While cases of drug-resistant infections, including HIV and TB, currently remain low in developed countries, the likelihood of rapid spread continues to grow as population size continues to increase.”

Dr. Jay Noller, Germinator scientific advisory board member, is designing a COVID-19 surface transmission remediation study focused on emerging variants in conjunction with colleagues at the Linus Pauling Institute, Oregon State University.

“Surface remediation of COVID-19 is essential and creates a precedent for other confounding public health threats to vulnerable populations,” said Noller. “Germinator’s HOCl Genesis solution complements the continuum of care of essential service provision in these challenging settings and affords enhanced public health protection, which complements the Global Health Security Agenda."